Carolina Raíssa Costa Picossi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carolina Raíssa Costa Picossi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Nori de Macedo
Departamento de Química Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Brazil
1 shared publication - Carolina Cavaliéri Gomes
Department of Pathology, Biological Sciences Institute, Universidade Federal de Minas Gerais (UFMG), Av. Presidente Antônio Carlos, 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil
1 shared publication - Filipe Fideles Duarte-Andrade
Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais (UFMG), Av. Presidente Antônio Carlos, 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil
1 shared publication - Flávia Leite-Lima
Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais (UFMG), Av. Presidente Antônio Carlos, 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil
1 shared publication - Gisele André Baptista Canuto
Departmento de Química Analítica, Instituto de Química, Universidade Federal da Bahia, Salvador, 40170-110, Brasil.
1 shared publication - Hélder Antônio Rebelo Pontes
Service of Oral Pathology, João de Barros Barreto University Hospital, Federal University of Pará, Belém, Brazil
1 shared publication
Latest Publications
- Open Access
- 20 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1802
Malignant Transformed and Non-Transformed Oral Leukoplakias Are Metabolically Different
Understanding the early molecular events driving oral carcinogenesis is vital for diagnosing oral squamous cell carcinoma (OSCC) promptly. While metabolic differences between oral leukoplakia (OLK), OSCC, and healthy oral mucosa have been reported, the metabolic changes distinguishing malignant transformed OLKs (MT-OLK) from non-transformed OLKs (NT-OLK) remain unexplored. Here, we examine the metabolomic profiles of 5 cases of MT-OLK and 15 of NT-OLK to identify key predictive molecules using untargeted high-performance liquid chromatography-mass spectrometry. The potentially discriminant compounds were highlighted through a robust statistical analysis workflow, and the dysregulated metabolic pathways were illustrated by enrichment analysis. Seventeen molecular features, primarily lipids—including phospholipids, oxidised lipids, cholesteryl esters, and fatty acids—were identified as discriminants between MT-OLK and NT-OLK across statistical and bioinformatic approaches. Pathway enrichment analysis revealed alterations in lipid metabolism, particularly fatty acid synthesis and degradation, steroid hormone biosynthesis, and glycerophospholipid metabolism. Predictive models showed high accuracy (AUC = 0.88) in distinguishing the two groups. This study suggests that metabolomics has the potential to differentiate between MT-OLK and NT-OLK by identifying candidate biomarkers that may contribute to the understanding of malignant transformation. Validation in larger cohorts is warranted to translate these findings into clinical practice.
- 20 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1802
Open AccessMalignant Transformed and Non-Transformed Oral Leukoplakias Are Metabolically Different
Understanding the early molecular events driving oral carcinogenesis is vital for diagnosing oral squamous cell carcinoma (OSCC) promptly. While metabolic differences between oral leukoplakia (OLK), OSCC, and healthy oral mucosa have been reported, the metabolic changes distinguishing malignant transformed OLKs (MT-OLK) from non-transformed OLKs (NT-OLK) remain unexplored. Here, we examine the metabolomic profiles of 5 cases of MT-OLK and 15 of NT-OLK to identify key predictive molecules using untargeted high-performance liquid chromatography-mass spectrometry. The potentially discriminant compounds were highlighted through a robust statistical analysis workflow, and the dysregulated metabolic pathways were illustrated by enrichment analysis. Seventeen molecular features, primarily lipids—including phospholipids, oxidised lipids, cholesteryl esters, and fatty acids—were identified as discriminants between MT-OLK and NT-OLK across statistical and bioinformatic approaches. Pathway enrichment analysis revealed alterations in lipid metabolism, particularly fatty acid synthesis and degradation, steroid hormone biosynthesis, and glycerophospholipid metabolism. Predictive models showed high accuracy (AUC = 0.88) in distinguishing the two groups. This study suggests that metabolomics has the potential to differentiate between MT-OLK and NT-OLK by identifying candidate biomarkers that may contribute to the understanding of malignant transformation. Validation in larger cohorts is warranted to translate these findings into clinical practice.